References
- Kent T H, Cardelli R M, Stamler F W. Small intestinal ulcers and intestinal flora in rats given indo-methacin. Am J Pathol 1969; 54: 237–245
- Brodie D A, Cook P G, Bauer B J, Dagle G E. Indo-methacin-induced intestinal lesions in the rat. Tox-icol Appl Pharmacol 1970; 17: 615–624
- Langman M JS, Morgan L, Worrall A. Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and haemorrhage. Br Med J 1985; 290: 347–349
- Madhok R, Mackenzie A, Lee F D. Small bowel ulceration in patients receiving non-steroidal anti-inflammatory drugs for rheumatoid arthritis. Q J Med 1986; 255: 53–58
- Rampton D S. Non-steroidal anti-inflammatory drugs and the lower gastrointestinal tract. Scand J Gastroenterol 1987; 22: 1–4
- Bjarnason I, Williams P, So A, et al. Intestinal permeability and inflammation in rheumatoid arthritis. Effects of non-steroidal anti-inflammatory drugs. Lancet 1984; 2: 1171–1174
- Auer I O, Habscheid W, Hiller S, Gerhards W, Eilles C. Nicht-steroidale Antiphlogistika erhöhen die Darmpermeabilität. Dtsch Med Wochenschr 1987; 112: 1032–1037
- Bjarnason I, Zanelli G, Smith T, et al. Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humans. Gastroenterology 1987; 93: 480–489
- Bjarnason I, Prouse P, Smith T, et al. Blood and protein loss via small-intestinal inflammation, induced by non-steroidal anti-inflammatory drugs. Lancet 1987; 2: 711–714
- Graham D Y, Smith J L, Spjut H J. Torres E. Gastric adaptation. Studies in humans during continuous aspirin administration. Gastroenterology 1988; 95: 327–333
- Patoia L, Clausi G, Farroni F, Alberti P, Fugiani P, Bufalino L. Comparison of faecal blood loss, upper gastrointestinal mucosal integrity and symptoms after piroxicam beta cyclodextrin, piroxicam and placebo administration. Eur J Clin Pharmacol 1989; 36: 599–604
- Fellows I W, Bhaskar N K, Hawkey C J. Nature and time-course of piroxican-induced injury to human gastric mucosa. Aliment Pharmacol Ther 1989; 3: 481–488
- Aabakken L, Larsen S, Osnes M. Cimetidine tablets or suspension in the prevention of gastrointestinal mucosal lesions caused by non-steroidal, anti-inflammatory drugs. Scand J Rheumatol 1989; 18: 369–375
- Aabakken L, Larsen S, Osnes M. Sucralfate for prevention of naproxen-induced mucosal lesions. Scand J Rheumatol 1986; 18: 361–368
- Aabakken L, Dybdahl J H, Eidsaunet W, Haaland A, Larsen S, Osnes M. Optimal assessment of NSAID induced gastrointestinal lesions. Endoscopic lesions, faecal blood loss and symptoms not necessarily correlated. Scand J Gastroenterol 1989; 24: 1007–1013
- Aabakken L, Bjernbeth B A, Hofstad B, Olaussen B, Larsen S, Osnes M. Comparison of the gastrointestinal side effects of Naproxen formulated as plain tablets, enteric-coated tablets, or enteric-coated granules in capsules. Scand J Gastroenterol 1989; 24(suppl 163)65–73
- Aabakken L, Larsen S, Osnes M. Visual analogue scales for endoscopic evaluation of NSAID-induced mucosal damage in the stomach and duodenum. Scand J Gastroenterol 1990; 25: 443–448
- Lehmann E L, d'Abrera H JM. Nonparametrics; statistical method based on ranks. Holden-Day Inc., San-Francisco 1975
- Lanza F L. Endoscopic studies of gastric and duodenal injury after the use of Ibuprofen, Aspirin, and other non-steroid antiinflammatory agents. Am J Med 1984; 77: 19–24
- Archambault A P, Rovelstad R A, Carlson H C. In situ pH of duodenal bulb contents in normal and duodenal ulcer subjects. Gastroenterology 1967; 52: 940–947
- Takeuchi K, Furukawa O, Tanaka H, Okabe S. Determination of acid-neutralizing capacity in rat duodenum. Influences of 16, 16-dimethyl prosta-glandin E2 and nonsteroidal antiinflammatory drugs. Dig Dis Sci 1986; 31: 631–637
- Domschke S, Domschke W. Gastroduodenal damage due to drugs, alcohol and smoking. Clin Gastroenterol 1984; 13: 405–436